Switch to हिंदी

Health, Fitness, Beauty & Diet | Pregnancy & Parenting | Diseases & Home Remedies | TheHealthSite.com

Health, Fitness, Beauty & Diet | Pregnancy & Parenting | Diseases & Home Remedies | TheHealthSite.com

हिंदी
  • Health A-Z
  • Home Remedies
  • Diseases
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Cancer
    • Heart Attack
    • Pneumonia
    • Diseases A-Z
  • Diet & Fitness
    • Weight Management
    • Exercise & Body Building
    • Diet & Recipes
    • Yoga
  • Coronavirus
  • News
  • Pregnancy
    • Conceiving
    • Infertility
    • Labour & Delivery
    • Pregnancy week-by-week
    • Breastfeeding
    • Baby Names
  • Beauty
    • Skin
    • Hair
    • Grooming
  • Photos
  • Videos
BLA21 cibil.com ageas federal zee hindustan
Home / Health News / TALENT study finds that made in India Supraflex stent clinically at par with Abbott’s Xience

TALENT study finds that made in India Supraflex stent clinically at par with Abbott’s Xience

The TALENT trial was conducted across 7 countries in Europe at 23 renowned centers with a sample size of 1435 patients.

By: Editorial Team   | | Updated: September 24, 2018 3:08 pm
Tags: Biodegradable stents  Cardiac stents  Stents  
bioabsorbable stents
Stents made in India prove to have better efficacy. © Shutterstock

Supraflex, a cardiac drug eluting stent designed and manufactured in India has been confirmed to be at par with Abbott’s Xience through an investigators-driven study called ‘TALENT’. Dr Patrick Serruys a globally renowned cardiology researcher was the chair for the TALENT trial. The findings of the TALENT trial were presented at the ‘late breaking trial session’ at Transcatheter Cardiovascular Therapeutics 2018 (TCT), the largest global conference of cardiologist currently underway in San Diego, USA. This study was conducted in 7 countries – United Kingdom, Netherlands, Poland, Spain, Italy, Hungary and Bulgaria – across 23 renowned centres with a sample size of 1435 patients. Xience is regarded as global standard in safety and efficacy for drug eluting stents. Also Read - Lancet says, Indian made stents safe, effective

Over 5,00,000 stents are used in India every year. A cardiac stent is a device used to unblock clogged arteries. Drug eluting stents are coated with medicines that help lower recurrence chances of an artery narrowing after corrective surgery. Also Read - Everything you need to know about angioplasty and stent replacement



Presenting the findings of TALENT trial, Dr Patrick Serruys, a globally renowned cardiologist with a history of path breaking global clinical trials was the study chair for TALENT study reportedly said, “Safety and efficacy of Supraflex SES with ultra thin struts and biodegradable polymer were compared with Xience EES in all comers-population. Supraflex was found to be non-inferior to the Xience for DOCE (device oriented end points) at 12 months in an all comer-population (open to more or less anyone who has the condition being studied) with a lower rate of CI-TLR clinically indicated target lesion revascularizationin the per protocol analysis.” Also Read - World’s first DUCTAL Stenting on the smallest baby performed in India

Padma Shri Dr Upendra Kaul, one of the leading cardiologist from India was the co-chair of the TALENT Study. Commenting on the study, Dr Kaul reportedly said, “There remained a perception that stents produced outside of India were superior to homegrown devices. There were demands from Indian manufacturers to prove that their devices are comparable to those made elsewhere in robust clinical trials. TALENT is the first such trial to yield positive results and stands out with a far better efficacy compared to the competitors.”

Prof. R. de Winter, MD, Academisch Medisch Centrum, Amsterdam, The Netherlands; and A. Zaman, MD, Cardiac Catheter Laboratories, Royal Freeman, Newcastle, UK, were the Principal Investigators for the TALENT trial. The TALENT trial included mean patient age of 65 years, and about three-quarters were men, with about 40% of patients presenting with stable angina and 60% with Acute Coronary Syndromes (ACS). The rate of a device-oriented composite endpoint of cardiac death, target-vessel MI, and clinically indicated TLR at 12 months was 4.9% with Supraflex and 5.3% with Xience, a difference that met criteria for non-inferiority (P< 0.001).

In a per protocol analysis Supraflex had better efficacy as compared to Xience. The rate of clinically driven re procedure rate was 1.2% vs 3.1% which was also statistically significant. The lower the re procedure rate the better it is. Supraflex is available in 65 countries across the world and is the largest selling drug eluting stent of SMT (Sahajanand Medical Technologies), India’s largest stent manufacturer. Supraflex has advanced features like biodegradable polymer and ultrathin strut* (60µm) thickness compared to 81 µm strut thickness and biostable polymer coating of Xience. The TALENT clinical study results matches with the published meta-analysis, highlighting benefits of lower strut thickness.

Mr Ganesh Sabat CEO, SMT reportedly said, “The result of the TALENT study is significant for the coronary stent industry. The success of this study resonates well with make in India. We are proud to establish India name in such a complicated and high end life-saving technology industry. We now have strong credentials to achieve our dream of becoming a leading global player in coronary stent industry.”

Published : September 24, 2018 3:08 pm | Updated:September 24, 2018 3:08 pm
Read Disclaimer

Contact lens may not be so cool and can cause rare eye infection, say doctors

Contact lens may not be so cool and can cause rare eye infection, say doctors

Are we nearing the end of the TB epidemic?

Are we nearing the end of the TB epidemic?

Please Wait. Article Loading ....

Coronavirus Updates

Coronavirus Updates

Stay Informed, Be Safe

  • Gurugram apartment declared containment zone after 20 tested positive for COVID-19
  • COVID-19 vaccine: Complete list of private hospitals where you can get the jab
  • COVID-19 vaccination for above 45: Full list of comorbidities that can make you eligible
  • Here's CoWIN 2.0 is different from its previous version
  • 'Do not let your guards down': Centre asks states to deal COVID-19 violations firmly

Health Calculators

BMI Calculator
bmi Calculator
Ideal Body Weight
ideal body weight
Daily Calorie Intake
Daily calorie intake
Calories Burned
calories burned

Related Stories

Lancet says, Indian made stents safe, effective

Lancet says, Indian made stents safe, effective

Everything you need to know about angioplasty and stent replacement

Everything you need to know about angioplasty and stent replacement

World’s first DUCTAL Stenting on the smallest baby performed in India

World’s first DUCTAL Stenting on the smallest baby performed in India

New technology that can identify blockages in the heart discovered

New technology that can identify blockages in the heart discovered

Health News in Hindi

Garlic Oil Benefits: त्वचा और बालों के लिए लहसुन के तेल के फायदे, जानें इस्तेमाल का सही तरीका

उम्र बढ़ने के साथ क्‍यों वजन कम कर पाना हो जाता है मुश्किल, जानिए वजन कम न कर पाने के कारण और बचाव

पीरियड्स के दौरान यीस्ट इंफेक्शन क्यों होता है? जानें यीस्ट इंफेक्शन को दूर करने के उपाय

Cardamom Side Effects: इलायची अधिक खाएंगे तो सेहत को हो सकते हैं ये 5 नुकसान

Beetroot Benefits For Skin And Hair: चुकंदर से करें बालों और त्‍वचा की हर समस्‍या का उपचार, जानिए कैसे

Read All

Recent Posts

  • US, China approve single-shot COVID-19 vax; India to get 3-4 vaccines in some weeks
  • Benefits of hair massage: Rujuta Diwekar shares the right way to do weekly Champi
  • COVID-19 vaccine at ₹250 too low to sustain, Companies ‘feel betrayed’: Kiran Mazumdar Shaw
  • Gurugram apartment declared containment zone after 20 tested positive for COVID-19
  • COVID-19 vaccine: Complete list of private hospitals where you can get the jab

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com
+91 – 22 – 6697 1234
Landline Phone number 91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

Useful Links

  • Weight Loss
  • Keto Diet Tips
  • Skin Care Tips
  • Intermittent Fasting
  • Apple Cider Vinegar
  • Ashwagandha
  • Cancer
  • Pneumonia
  • Diarrhoea
  • Dengue
  • Typhoid
  • Tuberculosis
  • Chickenpox
  • Chikungunya
  • Depression
  • Hepatitis
  • Diabetes
  • Type 2 diabetes
  • Arthritis
  • Swine Flu
  • Baby Names
  • Cough and cold
  • Heart Attack
  • Breast Cancer
  • Ebola Virus
  • Dengue
  • Malaria
  • International Yoga Day
  • Hypotension
  • Heart Failure
  • Asthma
  • Brain Tumour
  • Celebrity Fitness
  • Goitre
  • HIV/AIDS

We respect your privacy

  • Disclaimer
  • Privacy Policy
  • Contact Us
  • Author Profiles

Copyright © 2021 Zee Entertainment Enterprises Limited. All rights reserved.